Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis

PHASE2CompletedINTERVENTIONAL
Enrollment

741

Participants

Timeline

Start Date

January 6, 2010

Primary Completion Date

July 1, 2010

Study Completion Date

July 16, 2010

Conditions
Sinusitis, Acute
Interventions
DRUG

FFNS 110 mcg QD

Active Nasal Spray (AM) and Placebo Nasal Spray (PM)

DRUG

FFNS 110 mcg BID

Active Nasal Spray (AM) and Active Nasal Spray (PM)

DRUG

Placebo Nasal Spray

Placebo Nasal Spray (AM) and Placebo Nasal Spray (PM)

Trial Locations (87)

1000

GSK Investigational Site, Sofia

1319

GSK Investigational Site, Bekkestua

1527

GSK Investigational Site, Sofia

1606

GSK Investigational Site, Sofia

2317

GSK Investigational Site, Hamar

2408

GSK Investigational Site, Elverum

4011

GSK Investigational Site, Stavanger

7000

GSK Investigational Site, Rousse

9010

GSK Investigational Site, Varna

12157

GSK Investigational Site, Berlin

13057

GSK Investigational Site, Berlin

13619

GSK Investigational Site, Tallinn

14669

GSK Investigational Site, Ketzin

22143

GSK Investigational Site, Hamburg

28040

GSK Investigational Site, Madrid

30159

GSK Investigational Site, Hanover

45359

GSK Investigational Site, Essen

45600

GSK Investigational Site, Talavera de La Reina (Toledo)

47051

GSK Investigational Site, Duisburg

47574

GSK Investigational Site, Goch

60596

GSK Investigational Site, Frankfurt am Main

65009

GSK Investigational Site, Odesa

65183

GSK Investigational Site, Wiesbaden

69000

GSK Investigational Site, Zaporizhzhya

69469

GSK Investigational Site, Weinheim

90443

GSK Investigational Site, Nuremberg

95017

GSK Investigational Site, Symferopil

119881

GSK Investigational Site, Moscow

123095

GSK Investigational Site, Moscow

129010

GSK Investigational Site, Moscow

190013

GSK Investigational Site, Saint Petersburg

V2P 4M9

GSK Investigational Site, Chilliwack

V1Y 9L8

GSK Investigational Site, Kelowna

V4H 2H9

GSK Investigational Site, Surrey

R2V 4W3

GSK Investigational Site, Winnipeg

R3C 3J5

GSK Investigational Site, Winnipeg

L1S 2J5

GSK Investigational Site, Ajax

L6T 3T1

GSK Investigational Site, Brampton

P3E 1H5

GSK Investigational Site, Greater Sudbury

L8N 3Z5

GSK Investigational Site, Hamilton

N5W 6A2

GSK Investigational Site, London

L5A 3V4

GSK Investigational Site, Mississauga

L3Y 5G8

GSK Investigational Site, Newmarket

L1H 7K4

GSK Investigational Site, Oshawa

K1Y 4G2

GSK Investigational Site, Ottawa

N7T 4X3

GSK Investigational Site, Sarnia

M3H 5S4

GSK Investigational Site, Toronto

M4P 1P2

GSK Investigational Site, Toronto

M9W 4L6

GSK Investigational Site, Toronto

N4S 5P5

GSK Investigational Site, Woodstock

J2G 8Z9

GSK Investigational Site, Granby

H9R 4S3

GSK Investigational Site, Pointe-Claire

G1V 4M6

GSK Investigational Site, Québec

G1W 4R4

GSK Investigational Site, Québec

S7K 3H3

GSK Investigational Site, Saskatoon

256 30

GSK Investigational Site, Benešov

662 63

GSK Investigational Site, Brno

500 05

GSK Investigational Site, Hradec Králové

532 03

GSK Investigational Site, Pardubice

150 06

GSK Investigational Site, Prague

04509

GSK Investigational Site, Delitzsch

04626

GSK Investigational Site, Schmölln

1311 RL

GSK Investigational Site, Almere Stad

6191 JW

GSK Investigational Site, Beek

4872 LA

GSK Investigational Site, Etten-Leur

7581 BV

GSK Investigational Site, Losser

6525 EC

GSK Investigational Site, Nijmegen

3443 GG

GSK Investigational Site, Woerden

Unknown

GSK Investigational Site, Ålesund

GSK Investigational Site, Oviedo

N-3515

GSK Investigational Site, Hønefoss

N-5227

GSK Investigational Site, Nesttun

20-637

GSK Investigational Site, Lublin

33-100

GSK Investigational Site, Tarnów

50-556

GSK Investigational Site, Wroclaw

53-146

GSK Investigational Site, Wroclaw

47-120

GSK Investigational Site, Zawadzkie

08036

GSK Investigational Site, Barcelona

03503

GSK Investigational Site, Benidorm/Alicante

03610

GSK Investigational Site, Petrer/Alicante

SE-402 76

GSK Investigational Site, Gothenburg

SE-411 21

GSK Investigational Site, Gothenburg

SE-181 58

GSK Investigational Site, Lidingö

SE-221 85

GSK Investigational Site, Lund

SE-141 86

GSK Investigational Site, Stockholm

01103

GSK Investigational Site, Kyiv

03057

GSK Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01018030 - Dose Finding Study of Fluticasone Furoate Nasal Spray for Uncomplicated Acute Rhinosinusitis | Biotech Hunter | Biotech Hunter